Hereditary Abnormal Transcobalamin II Previously Diagnosed as Congenital Dihydrofolate Reductase Deficiency
- 22 March 1984
- journal article
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 310 (12), 789-790
- https://doi.org/10.1056/nejm198403223101217
Abstract
To the Editor: In 1976 Tauro et al.1 described two children in whom megaloblastic anemia occurred at birth and four weeks, respectively. The authors ascribed the condition to congenital deficiency of dihydrofolate reductase. The children were treated with folinic acid, and both had excellent hematologic responses. In 1978 we reinvestigated Case 2 of that report, because of the development of mental retardation and severe neuropathy after two years of treatment with folinic acid. The clinical details are described elsewhere.2 The blood count showed the following values: hemoglobin, 11.0 g per deciliter, packed cell volume, 34.5 per cent, red cells, 4.63x10 . . .Keywords
This publication has 4 references indexed in Scilit:
- Solid-phase immunoassay for the vitamin B12-binding protein transcobalamin II in human serumAnalytical Biochemistry, 1982
- Neurological involvement in hereditary transcobalamin II deficiency.Journal of Neurology, Neurosurgery & Psychiatry, 1982
- Studies of a Patient with Megaloblastic Anemia and an Abnormal Transcobalamin IINew England Journal of Medicine, 1980
- Dihydrofolate Reductase Deficiency Causing Megaloblastic Anemia in Two FamiliesNew England Journal of Medicine, 1976